Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 4
2015 5
2016 7
2017 4
2018 3
2019 5
2020 8
2021 14
2022 10
2023 8
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Perspectives on benefits and risks of creation of an "injection drug use" billing code.
Sundaram G, Sato T, Goodman-Meza D, Haddad M, Thakarar K, Feinberg J, Springer SA, Barton K, Butler N, Eaton EF, Wurcel AG. Sundaram G, et al. Among authors: goodman meza d. J Subst Use Addict Treat. 2024 May 10:209392. doi: 10.1016/j.josat.2024.209392. Online ahead of print. J Subst Use Addict Treat. 2024. PMID: 38735482
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perera V, Ward JW, Hiebert L, Degenhardt L, Hajarizadeh B, Colledge S, Hickman M, Jawad D, Lazarus JV, Matthews GV, Scheibe A, Vickerman P, Dore GJ, Grebely J; Global HCV and HIV Treatment Restrictions Group. Marshall AD, et al. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):366-382. doi: 10.1016/S2468-1253(23)00335-7. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367631 Review.
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study).
Goodman-Meza D, Shoptaw S, Hanscom B, Smith LR, Andrew P, Kuo I, Lake JE, Metzger D, Morrison EAB, Cummings M, Fogel JM, Richardson P, Harris J, Heitner J, Stansfield S, El-Bassel N; HPTN 094 Study Team. Goodman-Meza D, et al. Trials. 2024 Feb 15;25(1):124. doi: 10.1186/s13063-023-07899-5. Trials. 2024. PMID: 38360750 Free PMC article.
Addressing opioid use disorder: Mexico's step backwards.
Strathdee SA, Goodman-Meza D, Rafful CM. Strathdee SA, et al. Among authors: goodman meza d. Lancet Reg Health Am. 2023 May 23;23:100520. doi: 10.1016/j.lana.2023.100520. eCollection 2023 Jul. Lancet Reg Health Am. 2023. PMID: 37497392 Free PMC article. No abstract available.
68 results